Evaluation of Role of Ultrasound TA,TV,TP in Diagnosis of Placenta Previa and MAP(Morbidly Adherent Placenta )
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Morbidly Adherent Placenta
- Sponsor
- Aljazeera Hospital
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.
Detailed Description
The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.
Investigators
Mahmoud Alalfy
Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital
Aljazeera Hospital
Eligibility Criteria
Inclusion Criteria
- •pregnant ladies with previous cesarean sections
- •GA above 30 weeks
Exclusion Criteria
- •Primigravida patients
- •GA below 30 weeks
Outcomes
Primary Outcomes
number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US
Time Frame: within 6 weeks